mpany Share (%), 2010 38Figure 22: Key Parameters Monitored by Multiparameter Patient Monitors 40Figure 23: Non-Invasive Blood Pressure Monitors, Market Segmentation, 2011 41Figure 24: Non-Invasive Blood Pressure Monitors Market, China, Revenue ($m), 2003- 2010 42Figure 25: Non-Invasive Blood Pressure Monitors Market, China, Revenue ($m), 2010-2017 43Figure 26: Non-Invasive Blood Pressure Monitors Market, India, Revenue ($m), 2003-2010 44Figure 27: Non-Invasive Blood Pressure Monitors Market, India, Revenue ($m), 2010-2017 45Figure 28: Non-Invasive Blood Pressure Monitors Market, Brazil, Revenue ($m), 2003-2010 46Figure 29: Non-Invasive Blood Pressure Monitors Market, Brazil, Revenue ($m), 2010-2017 47Figure 30: Non-Invasive Blood Pressure Monitors Market, China, Company Share (%), 2010 48Figure 31: Non-Invasive Blood Pressure Monitors Market, India, Company Share (%), 2010 49Figure 32: Non-Invasive Blood Pressure Monitors Market, Brazil, Company Share (%), 2010 50Figure 33: Patient Monitoring Accessories, Market Segmentation, 2011 52Figure 34: Patient Monitoring Accessories Market, China, Revenue ($m), 2003-2010 53Figure 35: Patient Monitoring Accessories Market, China, Revenue ($m), 2010-2017 54Figure 36: Patient Monitoring Accessories Market, India, Revenue ($m), 2003-2010 55Figure 37: Patient Monitoring Accessories Market, India, Revenue ($m), 2010-2017 56Figure 38: Patient Monitoring Accessories Market, Brazil, Revenue ($m), 2003-2010 57Figure 39: Patient Monitoring Accessories Market, Brazil, Revenue ($m), 2010-2017 58Figure 40: Patient Monitoring Accessories Market, China, Company Share (%), 2010 59Figure 41: Patient Monitoring Accessories Market, India, Company Share (%), 2010 60Figure 42: Patient Monitoring Accessories Market, Brazil, Company Share (%), 2010 61Figure 43: Micro-Electromechanical Systems Market, China, Revenue ($m), 2003-2010 63Figure 44: Micro-Electromechanical Systems Market, China, Revenue ($m), 2010-2017 64Figure 45: Micro-Electromechanic
'/>"/>SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related medicine technology :1.
Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average2.
Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-20123.
Watching, Reading and Listening: A New Way to Interact with Patient Information4.
Phreesia identifies over 26% of patients who require additional autism evaluation5.
Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study6.
Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan7.
Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma8.
New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease9.
Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance10.
Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date11.
Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way